Table 3 Health results of PCVs for Peru over the life-time of the cohort
| Â | Â | QALYs/LYs gaineda | ||
|---|---|---|---|---|
| Â | Â | PCV-7 | PCV-13 | PHiD-CV |
Pneumococcal ID | QALYs - morbidity | 259.3 | 356.1 | 340.2 |
| Â | QALYs - mortality | 1,613.0 | 2,223.0 | 2,129.0 |
NTHi ID | QALYs - morbidity | 0 | 0 | 12.3 |
| Â | QALYs - mortality | 0 | 0 | 44.0 |
Pneumonia | QALYs - morbidity | 41.5 | 47.4 | 47.4 |
| Â | QALYs - mortality | 8,526.0 | 9,759.0 | 9,759.0 |
AOM | QALYs - morbidity | 50.5 | 109.0 | 196.0 |
Total QALYs gained | 10,490.3 | 12,494.5 | 12,527.9 | |
Total LYs gained | 11,847.0 | 14,000.0 | 13,942.0 | |